Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ACAD
ACAD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACAD News
EMA Committee Votes Against Acadia's Trofinetide Application
Feb 03 2026
Benzinga
Acadia Pharmaceuticals Shares Drop Over 8% After EMA Negative Trend Vote
Feb 02 2026
stocktwits
Acadia Pharmaceuticals to Present at 2026 J.P. Morgan Healthcare Conference
Dec 18 2025
Newsfilter
Acadia Receives FDA Approval for DAYBUE STIX Treatment of Rett Syndrome
Dec 12 2025
Newsfilter
FDA Grants Approval for Acadia's Powder Formulation of DAYBUE to Treat Rett Syndrome
Dec 12 2025
NASDAQ.COM
Evaluating ACADIA Pharmaceuticals' Valuation Following Significant Share Price Surge in 2024
Dec 06 2025
Yahoo Finance
Reasons Behind Dyne Therapeutics Stock Surge This Week
Nov 21 2025
NASDAQ.COM
In-Depth Insights: 6 Analysts Weigh In on ACADIA Pharmaceuticals Stock
Nov 06 2025
Benzinga
Needham Reaffirms Buy Rating on ACADIA Pharmaceuticals and Increases Price Target to $29
Nov 06 2025
Benzinga
Acadia Revises 2025 Projections, Aims for Over $1B in Revenue as DAYBUE and NUPLAZID Achieve Significant Growth Milestones
Nov 06 2025
SeekingAlpha
Acadia: Overview of Third Quarter Earnings
Nov 05 2025
Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
Oct 28 2025
PRnewswire
Innovative Approaches to Address Challenging Medical Conditions Beyond Conventional Medications
Oct 21 2025
Newsfilter
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
Oct 18 2025
PRnewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
Oct 03 2025
PRnewswire
Acadia Pharmaceuticals Showcases Clinical Findings from Various Therapeutic Programs at the 2025 International Congress on Parkinson's Disease and Movement Disorders®
Oct 02 2025
Newsfilter
Show More News
